Last updated on April 18, 2014 at 17:24 EDT

Latest Graham Kelly Stories

2013-11-06 08:30:00

SYDNEY, Nov. 6, 2013 /PRNewswire/ -- Novogen Limited (Australian Securities Exchange: NRT and NASDAQ: NVGN), an Australian biotechnology company dedicated to developing drugs that provide long-term remission through the successful control of cancer stem cells, today announced a joint venture with Yale University dedicated to developing personalized approaches to chemotherapy to fight ovarian cancer. The joint venture, which will be based near Yale's campus in New Haven, CT, will be...